PSG

Specialty pharmacy expenditures continue to grow consistently at an annual rate of 15-20 percent, with growth expected to continue at double-digit rates for the foreseeable future. This challenge is complicated by the fact that 50 percent or more of the specialty spend is covered under the medical benefit, where it frequently goes unmeasured and unmanaged.

How Well are You Managing Your Specialty Drug Spend?

In the RxDiagnostic for Specialty, we conduct a thorough review of plan design, vendor performance, clinical, and reimbursement management. Our proprietary process identifies drivers of specialty drug cost and utilization, as well as analyzing the effectiveness of your current program and identifying opportunities to improve the financial, clinical, and operational components of program performance.

The Result

Through this analysis, you will better understand and can more effectively manage specialty pharmaceutical spend, which often represents your fastest growing health care expense.